Watch Demo

Germany Nucleic Acid Testing/NAT Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

Germany Nucleic Acid Testing/NAT Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

  • Publish Date:July 2019

  • Number of Pages:1125

  • Report ID:5793810

  • Format:PDF

  • Publisher:Venture Planning Group

$ 3500

Summary

Germany Nucleic Acid Testing/NAT Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

Highlights

  • Comprehensive 1,125-page market segmentation analysis of the German NAT market.
  • Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:
                 - Infectious Diseases
                 - Cancer
                 - Forensic Testing
                 - Genetic Diseases
                 - Paternity Testing/HLA Typing
  • Review of testing methodologies and instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

    Contains 1,125 pages and 58 tables


    Companies Profiled
    Competitive Assessments

    - Abbott
    - Affymetrix
    - Agilent Technologies
    - Applied Gene Technologies
    - Arca Biopharma
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biokit
    - bioMerieux
    - Bio-Rad
    - Biotest
    - Cepheid
    - Decode Genetics
    - Diadexus
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Exact Sciences
    - Fujirebio
    - Grifols
    - Hologic
    - Illumina
    - LabCorp
    - Leica Biosystems
    - Li-Cor Biosciences
    - Myriad Genetics
    - Ortho-Clinical Diagnostics
    - PerkinElmer
    - Proteome Sciences
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - Shimadzu
    - Siemens Healthineers
    - Sierra Molecular
    - Takara Bio
    - Tecan Group
    - Thermo Fisher

Table of contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.